2023 Form 5500 filing — Galephar Pharmaceutical Retirement Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241002161334NAL0008608385001) for Galephar Pharmaceutical Retirement Plan, reported by Galephar Pharmaceutical Research Inc under EIN 66-0965645 and plan number 001. It reports 0 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241002161334NAL0008608385001
Filing year
2023
Form type
2
Plan sponsor
Galephar Pharmaceutical Research Inc
EIN
66-0965645
Plan number
001
Location
Humacao, PR
Participants
0
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$222,035
Total liabilities (EOY)
$0
Net assets (EOY)
$222,035
Employer contributions
$34,296
Participant contributions
$175,868
Total income / additions
$227,573
Benefits paid
$884
Administrative expenses
$4,654
Total expenses
$5,538
Net increase / (decrease)
$222,035
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Empower Annuity Insurance Company ORECORDKEEPER$3,940$0
Modern Capital Securities IncINVESTMENT ADVISOR$470not reported in the loaded dataset
Pension Administrators Group IncCONTRACT ADMIN$278not reported in the loaded dataset
Empower Advisory Group, LLCINVESTMENT MGMT$15not reported in the loaded dataset

Related Form 5500 pages